Johnson & Johnson and Subsidiaries Condensed Consolidated Statement of Earnings (Unaudited; in Millions Except Per Share Figures) Percent Percent Percent Increase Amount to Sales Amount to Sales (Decrease) Sales to customers 23,426 $ 100.0 22,321 $ 100.0 5.0 Cost of products sold 7,598 32.4 7,063 31.7 7.6 Gross Profit 15,828 67.6 15,258 68.3 3.7 Selling, marketing and administrative expenses 5,938 25.4 5,432 24.3 9.3 Research and development expense 3,462 14.8 3,178 14.2 8.9 In-process research and development 610 2.6 - - Interest (income) expense, net (12) (0.1) 48 0.2 Other (income) expense, net (102) (0.4) (882) (3.9) Restructuring 70 0.3 53 0.2 Earnings before provision for taxes on income 5,862 25.0 7,429 33.3 (21.1) Provision for taxes on income 713 3.0 1,232 5.5 (42.1) Net earnings 5,149 22.0 6,197 27.8 (16.9) Net earnings per share (Diluted) 1.93 $ 2.32 $ (16.8) Average shares outstanding (Diluted) 2,666.5 2,672.7 Effective tax rate 12.2 % 16.6 % Adjusted earnings before provision for taxes and net earnings (1) Earnings before provision for taxes on income 8,218 $ 35.1 8,291 $ 37.1 (0.9) Net earnings 7,129 $ 30.4 6,924 $ 31.0 3.0 Net earnings per share (Diluted) 2.67 $ 2.59 $ 3.1 Effective tax rate 13.3 % 16.5 % (1) See Reconciliation of Non-GAAP Financial Measures. FIRST QUARTER 2022 2021 -- 1 of 1 --